This is not the most recent version of the article. View current version (4 SEP 2014)

Intervention Review

Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia

  1. Helle Krogh Johansen*,
  2. Peter C Gøtzsche

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 24 JUL 2000

Assessed as up-to-date: 18 JUL 2011

DOI: 10.1002/14651858.CD000969


How to Cite

Johansen HK, Gøtzsche PC. Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD000969. DOI: 10.1002/14651858.CD000969.

Author Information

  1. Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

*Helle Krogh Johansen, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 3343, Copenhagen, DK 2100, Denmark. hkj@cochrane.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JUL 2000

SEARCH

This is not the most recent version of the article. View current version (04 SEP 2014)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.